Work

Esperienza di terapia con CAR-T axi-cel in paziente anziano, affetto da DLBCL double expressor in stadio avanzato e refrattario a chemio-immunoterapia di prima linea

Year: 2025

Type: article

Abstract: We hereby describe a case of successful therapy with axicabtagene ciloleucel (axi-cel) chimeric antigen receptor T-cells (CAR-T) in an elderly patient suffering from DLBCL refractory to first-line chemoimmunotherapy, with particular reference to the setting of the diagnostic/therapeutic path and collaboration between the Referral center and the CAR-T center.

Source: Recenti Progressi in Medicina

DOI: 10.1701/4450.44451

Author: Maria Goldaniga

Institution: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Gilead Sciences